Search results
May 23, 2024 · Bausch Health is a company that offers a range of products for eye health, gastroenterology, and dermatology. Learn about its mission, careers, latest news, and shareholder results.
- Job Search
Bausch Health believes in equal opportunity for all, without...
- U.S. Product List
U.S. Product List - Home | Bausch Health
- Careers
Careers - Home | Bausch Health
- Investors
Bausch Health Companies Inc. is a global diversified...
- Job Search
Bausch Health develops, manufactures and markets products in various therapeutic areas, such as gastroenterology, neurology, dermatology and eye health. It operates in more than 90 countries and regions, with headquarters in Canada and the U.S.
Bausch Health is a global company that offers a diversified portfolio of health care products, including pharmaceuticals, medical devices and over-the-counter products. It has a core focus in eye health, gastrointestinal diseases and dermatology, and operates in various regions and markets.
Bausch Health Companies Inc. is a global, diversified pharmaceutical company whose mission is to improve people’s lives with our pharmaceutical products. We develop, manufacture and market a range of products primarily in gastroenterology, neurology, dermatology and international pharmaceuticals.
Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International, Inc.) is an American-Canadian multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders ...
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company that develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the...
Bausch Health is a global pharmaceutical company with products in gastroenterology, hepatology, neurology, dermatology, and eye health. Find news releases, SEC filings, stock price, events and annual reports on the investor relations page.